About Genae
Genae is a company based in Antwerp (Belgium) founded in 2005. The company has 37 employees as of December 31, 2021. Genae has completed 3 acquisitions, including E-Novex, Hilbert Paradox and MedicSense. Genae operates in a competitive market with competitors including SSI Strategy, Fusion Antibodies, Health Decisions, Antios Therapeutics and Everest Clinical Research, among others.
- Headquarter Antwerp, Belgium
- Employees 37 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genae Associates Nv
-
Annual Revenue
$12.72 M (USD)3as on Dec 31, 2019
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
123 Investment Managers
& 1 more
-
Employee Count
37
as on Dec 31, 2021
-
Investments & Acquisitions
E-Novex
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genae
Investors in Genae
Genae has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include 123 Investment Managers and Korys.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital investments are directed toward Europe.
|
Locked | Locked | Locked | |
|
Sustainable investing in conscious consumer, energy transition, and healthy living sectors.
|
Locked | Locked | Locked |
Investor details for Genae
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genae
Genae has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include E-Novex, Hilbert Paradox and MedicSense.
Investment portfolio details for Genae
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical data management platform is provided for healthcare operations.
|
Locked | Locked | 2015 | Locked | |
|
Web technology services for medical research are provided by E-Novex.
|
Locked | Locked | 2007 | Locked | |
|
Regulatory consultancy is provided to the medical device industry.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Genae
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Genae
Detailed financials for Genae
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genae Comparisons
Peer comparison for Genae
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genae
Genae operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SSI Strategy, Fusion Antibodies, Health Decisions, Antios Therapeutics and Everest Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance and medical affairs services are offered for drug development.
|
|
| Locked | Locked | Locked |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| Locked | Locked | Locked |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| Locked | Locked | Locked |
Innovative therapies for treating and curing viral diseases are developed.
|
|
| Locked | Locked | Locked |
Full-service clinical research services are provided to life science industries.
|
|
| Locked | Locked | Locked |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
Detailed competitors of Genae
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genae
Complete news archive for Genae
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genae
Genae was founded in 2005 and raised its 1st funding round 11 years after it was founded.
Genae is headquartered in Antwerp, Belgium.
As of Dec 31, 2021, the latest employee count at Genae is 37.
Annual revenue of Genae is $12.72M as on Dec 31, 2019.
Genae was founded in 2005 in Antwerp, Belgium, as a provider of clinical development services in the MedTech sector. Operations encompass trial design, patient recruitment, regulatory support, and use of real-world evidence to expedite approvals. A proprietary platform is utilized for data management and analysis across various therapeutic areas. End-to-end regulatory assistance is offered to address regional compliance needs for product marketing.
Genae's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group.
Genae has made 3 acquisitions, including E-Novex, Hilbert Paradox, and MedicSense.
Genae has 2 investors. Key investors include 123 Investment Managers, and Korys.